Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers

Arch Int Pharmacodyn Ther. 1987 Jul;288(1):109-19.

Abstract

The three angiotensin converting enzyme (ACE) inhibitors cilazapril, perindopril and CGS 14824A were administered for 8 days to, respectively, 6, 5 and 5 normotensive healthy volunteers maintained on an unrestricted salt intake. Before starting treatment, as well as on the last day of therapy, an ambulatory blood pressure profile was obtained with a semi-automatic blood pressure recorder (Remler M2000). An additional blood pressure recording was performed 1 month after the end of the 8-day course of treatment with cilazapril and CGS 14824A. Eight day ACE inhibition with any of the 3 drugs did not result in a consistent decrease of ambulatory blood pressure recordings. This suggests that in normotensive subjects on a free salt intake the renin-angiotensin system may not be a key determinant of blood pressure.

MeSH terms

  • Adult
  • Angiotensin II / blood
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Benzazepines / pharmacology
  • Blood Pressure / drug effects*
  • Cilazapril
  • Humans
  • Indoles / pharmacology
  • Male
  • Perindopril
  • Pyridazines / pharmacology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzazepines
  • Indoles
  • Pyridazines
  • Angiotensin II
  • Cilazapril
  • benazepril
  • Perindopril